1-20 of 39
Authors: Tracy T Batchelor
Save search
Sort by
Journal Article

DDDR-24. REAL WORLD EXPERIENCE USING THE IDH INHIBITOR IVOSIDENIB IN IDH MUTANT GLIOMA: TOLERABILITY AND OUTCOMES Free

PDF
Tyler Lanman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii130–viii131, https://doi.org/10.1093/neuonc/noae165.0509
Published: 11 November 2024
Journal Article

IMMU-13. TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS Open Access

PDF
Jasia Mahdi and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.384
Published: 18 June 2024
Journal Article

Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making Free

PDF
Mary Jane Lim-Fat and others
Neuro-Oncology, Volume 24, Issue 7, July 2022, Pages 1140–1149, https://doi.org/10.1093/neuonc/noab282
Published: 08 December 2021
Journal Article

Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma Free

PDF
Chong Hyun Suh and others
Neuro-Oncology, Volume 24, Issue 3, March 2022, Pages 482–491, https://doi.org/10.1093/neuonc/noab234
Published: 06 October 2021
Journal Article

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG) Open Access

PDF
Ramon F Barajas and others
Neuro-Oncology, Volume 23, Issue 7, July 2021, Pages 1056–1071, https://doi.org/10.1093/neuonc/noab020
Published: 09 February 2021
Journal Article

HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA Open Access

PDF
Abed Rahman Kawakibi and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii347, https://doi.org/10.1093/neuonc/noaa222.305
Published: 04 December 2020
Journal Article

Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype Free

PDF
Jian Teng and others
Neuro-Oncology, Volume 22, Issue 12, December 2020, Page 1894, https://doi.org/10.1093/neuonc/noaa166
Published: 28 October 2020
Journal Article
EDITOR'S CHOICE

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions Free

PDF
Patrick Y Wen and others
Neuro-Oncology, Volume 22, Issue 8, August 2020, Pages 1073–1113, https://doi.org/10.1093/neuonc/noaa106
Published: 24 April 2020
Journal Article
EDITOR'S CHOICE

Biological activity of weekly ONC201 in adult recurrent glioblastoma patients Free

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology, Volume 22, Issue 1, January 2020, Pages 94–102, https://doi.org/10.1093/neuonc/noz164
Published: 08 November 2019
Journal Article

Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement Open Access

PDF
Ken Chang and others
Neuro-Oncology, Volume 21, Issue 11, November 2019, Pages 1412–1422, https://doi.org/10.1093/neuonc/noz106
Published: 13 June 2019
Journal Article
EDITOR'S CHOICE

Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology Free

PDF
Sebastian F Winter and others
Neuro-Oncology, Volume 21, Issue 9, September 2019, Pages 1118–1130, https://doi.org/10.1093/neuonc/noz048
Published: 04 March 2019
Journal Article

Accelerated progression of IDH mutant glioma after first recurrence Free

PDF
Julie J Miller and others
Neuro-Oncology, Volume 21, Issue 5, May 2019, Pages 669–677, https://doi.org/10.1093/neuonc/noz016
Published: 22 January 2019
Journal Article

Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma Free

PDF
Tejus A Bale and others
Neuro-Oncology, Volume 21, Issue 5, May 2019, Pages 596–605, https://doi.org/10.1093/neuonc/noy201
Published: 28 November 2018
Journal Article

Introduction of novel agents in the treatment of primary CNS lymphoma Free

PDF
Christian Grommes and others
Neuro-Oncology, Volume 21, Issue 3, March 2019, Pages 306–313, https://doi.org/10.1093/neuonc/noy193
Published: 13 November 2018
Journal Article

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma Free

PDF
Christian Grommes and others
Neuro-Oncology, Volume 21, Issue 3, March 2019, Pages 296–305, https://doi.org/10.1093/neuonc/noy192
Published: 12 November 2018
Journal Article

Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss Free

PDF
Morgan L Prust and others
Neuro-Oncology, Volume 20, Issue 2, February 2018, Pages 289–291, https://doi.org/10.1093/neuonc/nox217
Published: 05 January 2018
Journal Article

Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype Free

PDF
Jian Teng and others
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 642–654, https://doi.org/10.1093/neuonc/nox198
Published: 01 November 2017
Journal Article

Glioblastoma in elderly patients: solid conclusions built on shifting sand? Free

PDF
Antje Wick and others
Neuro-Oncology, Volume 20, Issue 2, February 2018, Pages 174–183, https://doi.org/10.1093/neuonc/nox133
Published: 18 July 2017
Journal Article

Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models Free

PDF
Jian Teng and others
Neuro-Oncology, Volume 19, Issue 6, 1 June 2017, Pages 820–832, https://doi.org/10.1093/neuonc/now253
Published: 06 January 2017
Journal Article

Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas Free

PDF
Ganesh M. Shankar and others
Neuro-Oncology, Volume 19, Issue 4, 1 April 2017, Pages 535–545, https://doi.org/10.1093/neuonc/now235
Published: 09 November 2016